BI 639667

CAS No. 1295298-26-8

BI 639667( BI639667 | BI-639667 )

Catalog No. M11194 CAS No. 1295298-26-8

BI 639667 (BI639667) is a potent and selective antagonist of human CCR1 with binding IC50 of 5.4 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 316 In Stock
5MG 281 In Stock
10MG 493 In Stock
25MG 924 In Stock
50MG 1311 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BI 639667
  • Note
    Research use only, not for human use.
  • Brief Description
    BI 639667 (BI639667) is a potent and selective antagonist of human CCR1 with binding IC50 of 5.4 nM.
  • Description
    BI 639667 (BI639667) is a potent and selective antagonist of human CCR1 with binding IC50 of 5.4 nM, inhibits chemotaxis with IC50 of 2.4 nM; shows good physico-chemical and pharmacokinetic properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BI639667 | BI-639667
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1295298-26-8
  • Formula Weight
    451.476
  • Molecular Formula
    C22H18FN5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (22.15 mM)
  • SMILES
    O=C(C1=CN=CC2=C1C=NN2C3=CC=C(F)C=C3)NC4(C5=CC(S(=O)(C)=O)=NC=C5)CC4
  • Chemical Name
    1-(4-fluorophenyl)-N-(1-(2-(methylsulfonyl)pyridin-4-yl)cyclopropyl)-1H-pyrazolo[3,4-c]pyridine-4-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • RS-102895

    A potent and specific CCR2 antagonist with binding IC50 of 360 nM; shows no significant affinity on CXCR1, CCR1, or CCR3. (IC50>17 uM).

  • GW-766994

    GW-766994 (GW766994) is a potent, selective, orally available CCR3 antagonist.

  • BMS-457

    BMS-457 is a potent and selective CCR1 antagonist with binding IC50 of 0.8 nM.